NCT05648058

Role of Nefopam in Rituximab Transfusion Reaction

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Ministry Of Health / Nineveh Health Directorate · Other Government
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

the patients will be taken nefopam ampule 50 mg before rituximab in the first group while the second group will be taken diphenhydramine ampule 10 mg before rituximab in the second group

Detailed description

the two groups will be taken standard therapy (hydrocortisone vial 100 mg and acetaminophen 1000 mg) 30 min before rituximab

Conditions

• Nefopam

Interventions

Type	Name	Description
DRUG	Nefopam ampule	nefopam ampule 50 mg
DRUG	diphenhydramine ampule	diphenhydramine ampule 10 mg

Timeline

• Start date: 2022-12-20
• Primary completion: 2023-10-20
• Completion: 2023-11-20
• First posted: 2022-12-13
• Last updated: 2022-12-15